Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Mobileye Global Inc. (NASDAQ:MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.

For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The company's previous implied guidance was $623 million-$648 million in revenue.

Wolfe Research analyst Shreyas Patil downgraded Mobileye Global from Outperform to Peer Perform.

Mobileye Global shares dipped 23.5% to $30.37 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Minim, Inc. (NASDAQ:MINM) shares jumped 170.2% to $4.62.
• Omega Therapeutics, Inc. (NASDAQ:OMGA) gained 92.7% to $5.26 after Novo Nordisk entered into a research collaboration with the company.
• Avenue Therapeutics, Inc. (NASDAQ:ATXI) shares climbed 65.8% to $0.2920 after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.
• Jeffs' Brands Ltd(NASDAQ:JFBR) gained 40% to $4.41 after surging 25% on Wednesday. Jeffs' Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology.
• Mobix Labs, Inc. (NASDAQ:MOBX) gained 33.3% to $4.00. Mobix Labs was awarded 15-month contract to supply EMI filtered connectors as part of US Army's M-1 Abrams Tank Program.
• ATIF Holdings Limited (NASDAQ:ATIF) jumped 30.6% to $1.32.
• Adicet Bio, Inc. (NASDAQ:ACET) surged 26.1% to $2.22. Adicet Bio issued corporate updates and highlighted upcoming priorities for its pipeline programs in 2024.
• Smart for Life, Inc. (NASDAQ:SMFL) gained 22.6% to $1.9999.
• XORTX Therapeutics Inc. (NASDAQ:XRTX) rose 21.7% to $2.97. Alliance Global Partners analyst James Molloy maintained XORTX Therapeutics with a Buy and raised the price target from $9 to $14.
• Kintara Therapeutics, Inc. (NASDAQ:KTRA) climbed 20.1% to $0.1690 after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value.
• QuantumScape Corporation (NYSE:QS) gained 18.5% to $7.70.
• The Arena Group Holdings, Inc. (NYSE:AREN) shares rose 16.8% to $2.44 after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn.
• NuZee, Inc. (NASDAQ:NUZE) gained 16.7% to $2.9999.
• Keros Therapeutics, Inc. (NASDAQ:KROS) gained 15.7% to $47.72. Keros Therapeutics priced upsized $140 million public offering of 3.5 million common shares at $40 per share.
• Dyne Therapeutics, Inc. (NASDAQ:DYN) gained 14.6% to $16.92. Dyne Therapeutics announced an underwritten public offering of $175 million of common stock.
• TMC the metals company Inc. (NASDAQ:TMC) rose 13.8% to $1.32.
• MINISO Group Holding Limited (NYSE:MNSO) gained 9.7% to $21.87.
• Nikola Corporation (NASDAQ:NKLA) rose 8.4% to $0.8031. Nikola said it produced 42 and wholesaled 35 Class 8 Nikola Hydrogen Fuel Cell Vehicles for US and Canada customers in 2023.
• Select Medical Holdings Corporation (NYSE:SEM) gained 6.4% to $25.00. Select Medical announced potential separation of Concentra.

Losers

• SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares fell 36% to $0.58 after the company announced pricing of $9.0 million public offering.
• E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 33.2% to $0.9894.
• OPKO Health, Inc. (NASDAQ:OPK) shares dipped 28% to $1.0799. OPKO Health disclosed a private offering of Convertible Senior Notes due 2029.
• Hitek Global Inc. (NASDAQ:HKIT) tumbled 25.2% to $0.77.
• Relmada Therapeutics, Inc. (NASDAQ:RLMD) declined 24% to $3.44 after the company issued a corporate update.
• Nemaura Medical Inc. (NASDAQ:NMRD) dipped 21.2% to $0.1009.
• ABVC BioPharma, Inc. (NASDAQ:ABVC) shares fell 20.1% to $1.5395. ABVC BioPharma shares jumped over 60% on Wednesday after the company and its subsidiary received a milestone payment of 46 million shares from AiBtl BioPharma under a global licensing payment.
• LifeMD, Inc. (NASDAQ:LFMD) fell 20.1% to $6.20.
• Singularity Future Technology Ltd. (NASDAQ:SGLY) tumbled 18.3% to $0.47.
• cbdMD, Inc. (NYSE:YCBD) dipped 16.1% to $0.8302.
• RiskOn International, Inc. (NASDAQ:ROI) shares fell 13.7% to $0.2536 after dipping around 35% on Wednesday.
• WW International, Inc. (NASDAQ:WW) tumbled 13.6% to $6.59.
• Pinstripes Holdings Inc. (NYSE:PNST) declined 13.1% to $7.13.
• Avanos Medical, Inc. (NASDAQ:AVNS) fell 12.9% to $18.91 after reporting preliminary Q4 and FY23 financial results.
• NexImmune, Inc. (NASDAQ:NEXI) fell 11.5% to $5.49 after jumping around 153% on Wednesday.
• Schnitzer Steel Industries, Inc. (NASDAQ:RDUS) declined 9.8% to $26.61 following first-quarter results.
• Evotec SE (NASDAQ:EVO) shares declined 9.2% to $9.60. Evotec and Owkin announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation.
• Walgreens Boots Alliance, Inc. (NASDAQ:WBA) dipped 8.5% to $23.39 following quarterly results.
• MultiPlan Corporation (NYSE:MPLN) fell 7.3% to $1.3150. MultiPlan named Travis Dalton as President and CEO on March 1, 2024.
• First Wave BioPharma, Inc. (NASDAQ:FWBI) shares fell 7.1% to $5.07. First Wave BioPharma shares jumped 43% on Wednesday after Roth MKM maintained a Buy rating on the stock and adjusted its target from $11 to $40.
• Altice USA, Inc. (NYSE:ATUS) fell 4.8% to $2.9310.

Now Read This: Bitcoin Rises Above $43,000 Following ADP Data; Beam Emerges As Top Gainer